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a B S t r a c t
OBjective: As noninvasive imaging is gaining widespread acceptance, the aim of 
the present study was to review our experience with the use of cross sectional imaging 
modalities to evaluate cardiac tumors and masses.
BackgrOund: Proper diagnosis of the type and extension of a cardiac tumor or mass 
is very important for therapy planning. Echocardiography has an established role as a 
non-invasive diagnostic imaging modality. Computed tomography (CT) and magnetic 
resonance imaging (MRI) also provide adequate delineation of cardiac tumors and 
masses.
MethOdS: Twenty-two patients referred to our department with a suspected cardiac 
mass, previously detected by cardiac ultrasound, were evaluated by CT (12 patients) 
and MRI (4 patients). Six patients were examined by both modalities. In 2 cases of 
staging of a known primary neoplasm and one case of a suspected epicardiac lesion, 
positron emission tomography (PET-CT) was performed. The CT cardiac examina-
tions were performed using a 16-slice multislice scanner with ECG gating. The MRI 
examination was performed on a 1.5 Tesla MRI scanner using an ECG-gated cardiac 
protocol and the PET-CT examination was performed on an integrated PET-CT four-
slice scanner, using 370 mMBq of fluorodeoxyglucose.
reSultS: Twenty-two cardiac masses were successfully detected and their character-
istics adequately delineated, including eight myxomas, one angiosarcoma, one ven-
tricular lymphoma, one endocardiac metastasis, one epicardiac paraganglioma, and 
10 cases of intracardiac thrombi.
cOncluSiOn: CT and MRI are noninvasive imaging modalities which can delineate 
cardiac tumors and masses and provide essential information for adequate diagnosis, 
staging and treatment planning. Compared to cardiac ultrasound, CT and MRI are 
superior in preoperative planning.
i n t r O d u c t i O n
Cardiac tumors are rare in everyday clinical practice; nevertheless, they represent 
an important group of tumors that require investigation for proper diagnosis and 
treatment. Echocardiography has been the only reliable non-invasive diagnostic tool 
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AbbreviAtions
CT = computed tomography
MRI = magnetic resonance imaging
PET/CT = positron emission tomography
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until the past decade. Although computed tomography (CT), 
magnetic resonance imaging (MRI) and positron emission 
tomography (PET-CT) are gaining widespread acceptance, 
CT can locate, differentiate, confirm or exclude the presence 
of a cardiac mass and it is thus regarded essential for adequate 
staging.1 Additionally, it provides detailed information of 
cardiac and vascular anatomy related to the mass, which al-
lows proper therapy planning. The role of MRI has also been 
demonstrated in the assessment and differential diagnosis of 
cardiac tumors, inflammatory disease, storage disease and 
cardiomyopathies.2 Both modalities may confirm or exclude 
the presence of intra-cardiac thrombi. Additionally cardiac 
function and flow may be evaluated by MRI.
The aim of the present study was to review our experience 
with the use of these newer imaging modalities in evaluating 
cardiac tumors and masses in 22 patients referred for further 
evaluation after an initial echocardiographic examination.
M e t h O d S
We examined 22 patients (17 males and 5 females), referred 
to our department from April 2004 until November 2009, with 
a suspected cardiac mass detected by cardiac ultrasound. The 
review of the records of these patients, as well as the publication 
of the data of this study was approved by the hospital ethics 
committee. A CT scan was performed in 12 patients, MRI in 
4 patients and 6 patients were examined by both modalities. A 
PET-CT scan was performed in one patient with a suspected 
epicardiac lesion detected by echocardiography and another 
patient for staging of melanoma.
All CT cardiac examinations were performed using a 16-
slice multislice scanner, with ECG gating. Reconstructions 
of images were performed between phase 70% and 75% of 
the cardiac cycle due to better spatial resolution. Image post-
processing was performed on a workstation. Images were 
acquired before the injection of contrast medium in order to 
evaluate calcifications and were followed by the injection of 
non-ionic iodinated contrast medium, 370 mgI/ml, using an 
injector with a rate of 3.3-3.5 ml/sec through an antecubital 
vein; 20 ml of saline solution was injected to flush the vein 
(saline chaser).
The MRI examinations were performed on a 1.5 Tesla 
MRI scanner using an ECG-gated cardiac protocol. The 
examination started with a morphological overview, which 
covered the entire heart by using fast spin-echo sequences, 
single-shot gradient-echo sequences and steady-state free 
precession sequences, reducing the examination time. Initial 
morphological analysis was followed by soft tissue charac-
terization techniques, T1-weighted pre- and post contrast 
medium injection and T2-weighted fast spin-echo sequence. 
These techniques were applied to the region of the tumors.1 
T1-weighted, T2-weighted, inversion recovery sequences and 
T2 gradient-echo sequences were also used for identifying 
the presence of possible calcifications or hemorrhages in the 
tumor. Enhancement evaluation of the tumors was performed 
by injection of contrast medium 0.1 mmol/kg by an injector 
through an antecubital vein. Delayed- enhancement gradient-
echo sequences were performed to define the extent of the 
mass. Post-processing was performed on a workstation.
The PET-CT examination was performed on an integrated 
PET-CT four-slice scanner. A total of 370 mMBq of fluorode-
oxyglucose (FDG) was injected intravenously one hour before 
the examination was initiated and all PET and CT images 
were attenuation corrected and fussed in three planes and 
were evaluated on a workstation.
r e S u l t S
Twelve cardiac tumors were detected including eight 
myxomas (Fig. 1-4), one angiosarcoma (Fig. 5), one ventricular 
lymphoma (Fig. 6), one endocardiac metastasis (Fig. 10) and 
one epicardiac paraganglioma (Fig. 7). Ten cases of intra-
cardiac thrombi were detected (Fig. 8 & 9). The lymphoma 
case was further proven by biopsy; the myxomas, sarcoma, 
and paraganglioma were surgically confirmed. Three more 
metastases were detected by PET-CT in the patient with the 
melanoma metastases.
The exact location of the tumors and masses detected was 
as follows: eight myxomas in the left atrium, four thrombi in 
the left ventricle and six in the right atrium. The angiosarcoma 
was located in the right atrium. One lymphoma was detected 
in the right ventricle, the paraganglioma on the epicardium, 
specifically in the left atrioventricular groove and a metastasis 
was detected in the endocardium of the left atrium. The CT 
and MRI findings were similar with those of echocardiography 
with regards to the myxomas and thrombi, while small differ-
ences concerning mass sizes were reported.
The size of the myxomas ranged between 1.5 and 6 cm. 
Three of them were partially calcified and one was totally 
calcified (Fig. 4), two were papillary and two were prolapsing 
through the mitral valve. The size of the intracardiac thrombi 
ranged between 1 and 4 cm. Seven thrombi were located in 
the right atrium (one particularly in the crista terminalis) and 
the remainder (n=3) in the left ventricle. A left ventricular 
aneurysm was detected in two of these cases post myocardial 
infarction. The angiosarcoma was located in the right atrium 
and infiltrated the atrial septum and the pericardium causing 
hemopericardium (Tables 1 & 2).
d i S c u S S i O n
Echocardiography fulfils the clinician’s expectations in 
the vast majority of cases in the detection of cardiac masses. 
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Availability, cost, operator expertise and the image quality of 
ultrasound equipment today are all favoring echocardiography 
and this method remains the key examination in assessing 
cardiac tumors. However, echocardiography is still dependent 
on the patient’s acoustic window.
The advantage of MRI compared to CT is that it does not 
use ionizing radiation and can evaluate the function of the 
heart more reliably, while compared to echocardiography that 
it is independent of anatomical windows. The MRI techniques 
can produce 3D reconstructions of the heart oriented in any 
plane and with high contrast between muscular structures and 
blood.3,4 MRI provides a complete evaluation of the lesions 
involving cardiac chambers and the pericardium providing 
diagnostic information useful for surgical planning. Details 
of the tumors assessed are morphology, dimensions, location, 
Figure 1a, B. CT: Left atrium myxoma prolapsing in the left 
ventricle, through the mitral valve.
B
Figure 2. MRI: Left atrium myxoma.
a
Figure 3. Small pendunculated myxoma in the left atrium.
extension, presence of infiltration, and any signs that may allow 
characterization, such as adipose tissue, necrosis, hemorrhage, 
vascularization, calcifications, and myxoid tissue. Most often, 
diagnosis is based upon indirect and probabilistic findings, 
which can point to a specific type of tumor rather than another. 
In general, MRI is superior to CT due to better tissue char-
acterization and lack of ionizing radiation, a very important 
factor, especially when applying imaging techniques to children. 
Functional information concerning wall motility, valve function 
and flow may also provide information on tumors.
Echocardiography, scintigraphic methods and digital 
subtraction angiography are established modalities in the 
diagnosis of cardiac masses. With the introduction of multi-
slice CT with ECG-gating, temporal and spatial resolution 
of CT has improved. Computed tomography also identifies 
unexpected cardiac tumors in patients examined for other 
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thoracic pathology.
Cardiac tumors are classified as primary or secondary 
neoplasms due to metastasis or extension of malignancies 
located outside the heart. The prevalence of primary tumors 
is 0.0017-0.33%, whereas secondary tumors occur 20-40 times 
more often.1,5
Figure 4. Calcified myxoma in the left atrium protruding in 
the left ventricle.
Figure 5. Right atrium angiosarcoma infiltrating the atrial 
septum and the pericardium causing hemopericardium.
Figure 6. MRI: Lymphoma of the left ventricle infiltrating the 
myocardium.
Figure 7. a. PET/CT: Paraganglioma detected on the epicar-
dium, atrioventricular (AV) groove. B. MRI: High intensity le-
sion detected in the AV groove.
B
a
Neoplastic disease of the heart, whether primary or second-
ary, can present with symptoms and signs related to involvement 
of the pericardium, myocardium, and the cardiac cavity leading 
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Figure 9. CT: Thrombus in the right atrium (crista terminalis).
B
a
Figure 8 a, B. Massive venous thrombosis with cardiac in-
vasion as primary manifestation of hepatocellular carcinoma. 
Coronal view CT (a), MRI (b). Figure 10. PET/CT: Metastasis in the left atrium from mela-
noma.
to cavity or valve obliteration, but can also produce embolic 
phenomena. With pericardial involvement, the following can 
be observed: pericarditis, hemopericardium, tamponade as in 
our angiosarcoma case (Table 1), and arrhythmias. Myocardial 
involvement can present with arrhythmias, congestive heart 
failure as in our lymphoma case, angina and infarction due 
to coronary involvement.2 Intracavitary masses may mimic 
mitral stenosis; our two cases of prolapsing myxomas pre-
sented this way.
The most common primary cardiac neoplasm is the benign 
myxoma. It accounts for 30-35% of all primary cardiac tumors 
and for approximately 50% of all benign primary cardiac 
masses. The typical age of involvement is between 30 and 60 
years of age. Clinical presentation may mimic that of mitral 
valve disease. Hemolytic anemia is typically associated with 
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taBle 1. Clinical and imaging characteristic of the tumors
gender age diagnosis Modalities used Modality of confirmation characteristics of the lesions
1 Male 58 Myxoma uS, CT CT Totally calcified, prolapsing, 6 cm
2 Male 71 Myxoma uS, CT CT Partially calcified, 3.3 cm
3 Male 65 Myxoma uS, CT CT Partially calcified, 2.7 cm
4 Male 63 Myxoma uS, CT CT Homogenous, prolapsing, 5 cm
5 Female 55 Myxoma uS, CT CT Pendunculated, 2 cm
6 Female 59 Myxoma uS MRI Pendunculated, 1.8 cm
7 Male 63 Myxoma uS, CT, MRI MRI Partially calcified, 1.5 cm
8 Male 57 Myxoma uS, CT MRI Homogenous, solid, 3.5 cm
9 Male 73 Thrombus uS, CT CT Left ventricle, 2.5 cm
10 Male 72 Thrombus uS, MRI MRI Right atrium, 3.4 cm
11 Male 66 Thrombus uS, MRI MRI Right atrium, 1 cm
12 Male 69 Thrombus uS, MRI MRI Left ventricle, 4 cm
13 Female 52 Thrombus uS, CT, MRI MRI Right atrium, 2.9 cm
14 Female 49 Thrombus uS, CT CT Crista terminalis, 1.5 cm
15 Female 61 Thrombus uS, CT CT Left ventricle 1.8 cm
16 Male 62 Thrombus uS, CT CT Left ventricle, 2.7 cm
17 Male 58 Thrombus uS, MRI MRI Right atrium, 3.2 cm
18 Male 66 Thrombus uS,CT, MRI MRI Right atrium
19 Male 67 Angiosarcoma uS CT Infiltration of atrial septum and pericardium 
causing hemopericardium
20 Male 62 Lymphoma uS, PET-CT MRI Left ventricle infiltration
21 Male 59 Metastasis uS, PET-CT PET-CT Left atrium, 1 cm
22 Male 55 Paraganglioma uS PET-CT Epicardium, atrioventricular groove, 1.3 cm
CT= computed tomography; MRI= magnetic resonance imaging; PET-CT= positron emission tomography; uS= (cardiac) ultrasound
calcified myxomas. Atypical symptoms include syncope, weight 
loss, fatigue, fever, anemia, an elevated sedimentation rate and 
the presence of abnormal serum proteins.2 A myxoma syndrome 
is also described which is characterized by skin pigmentation 
and the presence of endocrine neoplasms. Tumor embolism 
occurs in approximately 50% of cardiac myxomas.6
Most of the myxomas (95%) are located within the atria, 
at the interartial septum at the level of the fossa ovalis, most 
commonly are left sided (75%), followed by the right atrium 
(20%) and the remainder may be encountered in either ven-
tricle. They are typically attached to the oval fossa by a stalk. 
A prolapsing myxoma may impair ventricular filling. They 
range in size from 1 to 15cm (average 5 cm) and may contain 
blood, thrombus or calcifications.2,7 The location, appearance 
and mobility of myxomas are characteristic. However, large 
vegetations, thrombus and other tumors must be excluded. 
Imaging modalities such as CT and MRI can provide additional 
information when echocardiography cannot delineate the extent 
of cardiac wall involvement. If the quantity of myxoid tissue 
is abundant, the lesion will have an elevated signal in the T2-
weighted images, whereas if the fibrous component prevails, 
the mass will appear hypointense. Enhancement of the tumor 
is correlated to its histology and the areas that do not enhance 
correspond to necrosis or cystic degeneration.8 Enhancement 
is the key difference between myxomas and thrombi; the latter 
do not enhance except in rare cases of vascularized thrombi.9 
We did not come across such thrombi in our series.
Papillary fibroelastoma is the second most common benign 
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cardiac tumor. It is made up of fibrous tissue, smooth elastic 
fiber and muscular cells. The structure is usually small, circular 
and adherent to the atrioventricular or semilunar valves. There 
are no definite descriptions on the behavior of the MRI signal 
and is usually diagnosed by ultrasound. Most are smaller than 
1 cm in diameter and attached to valves.10
Rhabdomyoma is the most common cardiac tumor seen 
in childhood. It is considered to be a hamartoma. It may be 
associated with tuberous sclerosis.11,12 It accounts for approxi-
mately 5% of all primary cardiac lesions. It may present as 
multiple intramyocardial masses which tend to be pedunculated 
and are most frequently found in the left ventricle. It tends 
to regress over time. Conduction problems or obstruction 
cause the symptoms, rarely hypoxic episodes have also been 
reported.13,14 When MRI is performed, it presents the same 
imaging characteristics as the myocardium on T1-weigheted 
plain fast spin-echo sequence. It enhances homogeneously, 
more than the normal myocardium.1
Fibromas account for approximately 5% of all primary 
cardiac lesions and may show progressive growth.15 They may 
present as coarse calcifications on CT and reduced signal on 
T2-weighted sequence in MRI.16 Lipomas can occur throughout 
the heart and pericardium. They are frequently round in ap-
pearance and vary in size from 2 to 8 cm. Patients may present 
with a pericardial effusion, supraventricular tachycardia and 
sudden death. The CT and MRI appearance of fat tissue is 
characteristic and the tumor characterization is easy.17
Primary malignant tumors account for 25-30% of all pri-
mary cardiac masses. Sarcomas account for nearly all primary 
malignant cardiac neoplasms; angiosarcoma is the most com-
mon. Patients typically present in their 20-40s with a strong 
male prevalence. It is associated with a poor prognosis and 
generally less than a 6-month survival. Our patient survived 
three weeks post-diagnosis.18 The right atrium is the predomi-
nant site of origin where the mural mass infiltrates the atrial 
wall and nearly obliterates the chamber. Patients may present 
with obstructive symptoms, heart failure and/or hemorrhagic 
pericardial effusion, dyspnea, hemoptysis, arrhythmias and 
heart block.19,20 Local invasion of adjacent structures have 
been described and distant metastases can also occur. CT 
depicts the tumor as an infiltrating mass extending along the 
myocardial wall and pericardium. Hemorrhage and necrosis 
is frequent and responsible for its heterogeneity. MRI detects 
heterogeneous peripheral contrast enhancement - “sun ray” 
appearance and nodular areas of increased intensity - “cau-
liflower appearance”.21 CT and MRI provide more anatomic 
taBle 2. Tumor imaging characteristics
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information concerning tumor extension and infiltration than 
echocardiography.
Rhabdomyosarcoma is the second most frequent primary 
malignant cardiac tumor and also exhibits a male predominance. 
Often, multiple lesions involving the valves are seen. On CT 
it appears as an irregular low attenuation lesion. On MRI it 
appears as an iso-intense lesion relative to the myocardium 
on an unenhanced T1-weighted sequence and presents hetero-
geneous signal intensity after intravenous contrast injection 
indicating necrosis.21
Extremely rare tumors include fibrosarcoma, liposarcoma, 
and hemangiopericytoma and fibrous histiocytoma. The first 
one tends to involve multiple sites and valves and has a low 
attenuation on plain CT. On MRI it is heterogeneous or isoin-
tense to myocardium on T1-weighted images. Liposarcoma 
is a large multilobulated tumor with necrosis. On MRI it is 
heterogeneous or has high signal intensity presenting with 
epicardial infiltration.21
Primary cardiac lymphoma is a non Hodgkin’s lymphoma 
involving only the heart and pericardium. The commonest 
presentation is cardiac failure. Manifestations include dyspnea, 
arrhythmias, superior vena cava obstruction, pericardial ef-
fusions, tamponade and chest pain.22 They commonly arise 
in the right atrium and ventricle. CT reveals a pericardial 
effusion and pericardial thickening and usually a polypoid 
mass or an ill defined infiltrative lesion. On MRI lymphomas 
have similar or lower intensity than cardiac muscle. Contrast 
reveals heterogeneous enhancement due to central necrosis.21 
The diagnosis is based on findings of the pericardial fluid 
and is usually confirmed by biopsy. It is important to have 
this tumor in the differential diagnosis since it can be treated 
effectively with chemotherapy. unfortunately we did not have 
the opportunity to scan the patient post-treatment.
Metastasis could occur by direct extension, lymphatic or 
venous hematogenous spread. Direct extension can occur in 
cases of lung, breast, and esophageal carcinoma. Lymphog-
enous spread can occur in cases of lung and breast carcinoma. 
Venous extension can occur in cases of renal cell carcinoma and 
hepatocellular carcinoma, whereas hematogenous spread is the 
main route of dissemination in cases of sarcoma, lymphoma, 
leukemia and melanoma. In our patient with the melanoma 
metastasis, multiple metastases were identified on the PET/CT 
exam and did not change the treatment plan. Isolated metas-
tases to the pericardium are rare. Patients may present with 
pericardial effusion, constriction, and tamponade.2
In one of our patients, previously diagnosed by PET-CT 
with multiple paragangliomas throughout his body, the para-
ganglioma of the heart was assessed by MRI, but results were 
inconclusive probably do to the fact that contrast media was 
not injected (Fig. 7b). PET/CT detected a lesion with high and 
homogenous 18-FDG uptake in the atrioventricular groove. 
The uptake was similar to the other body paragangliomas.
“Pseudotumors” usually represent a thrombus. They are 
the commonest intracardiac masses and may be detected in any 
cardiac chamber. On enhanced CT, thrombi have a hypodense 
appearance. On MRI the signal intensity varies according to the 
age of the thrombus.1 Intracardiac thrombi can be formed due 
to changes of surface properties, flow dynamics or changes in 
blood coagulation. Patients at risk are the ones with prosthetic 
heart valves, pacemakers, atrial fibrillation or dysfunctional 
ventricles. Additionally, the presence of a malignant tumor 
is a significant risk factor for cardiac thrombi, especially in 
cases of renal cell cancer, extension of tumor thrombus from 
the kidney through the inferior vena cava and into the right 
atrium is commonly encountered. On the contrary, hepato-
cellular carcinoma with tumor thrombus in the inferior vena 
cava and right atrium is not commonly observed.23 In one of 
our cardiac thrombi cases, a right atrial “pseudotumor”, first 
discovered by transthoracic cardiac ultrasound and further 
investigated by CT, was the primary manifestation of hepato-
cellular carcinoma. Computed tomography and MRI in this 
patient revealed a huge primary hepatocellular carcinoma 
with direct extension of the mass through the inferior vena 
cava into the right atrium.
Although there is no pediatric experience in our hospital, 
we will herein briefly review and compare the incidence of 
cardiac tumors between children and adults. Primary cardiac 
tumors are rare in the pediatric practice with a prevalence 
of 0.0017 to 0.28 in autopsy series. In contrast, the incidence 
of cardiac tumors during fetal life has been reported to be 
approximately 0.14%.24 Most of the tumors in childhood 
are benign, whilst approximately 10% are malignant, with 
secondary malignant tumors being 10 to 20 times more preva-
lent than primary ones.24 The most common cardiac tumor 
during fetal life and childhood is the rhabdomyoma with an 
incidence of 60% of all primary cardiac tumors.24 Teratomas 
are the second most common tumor in the fetus and neonate 
after rhabdomyoma (15-19%) and they are most commonly 
detected in the pericardial cavity, attached to the pulmonary 
artery and aorta.24 Fibroma, which is the third most common 
tumor in children (12-16%) is 5 times more prevalent than in 
adults, while myxoma is by far less frequent in the pediatric 
population (2-4% vs 65% in adults).24 Finally, primary and 
especially secondary malignant cardiac tumors are rare in 
both age groups, with rabdomyosarcomα and fibrosarcoma 
being the most common primary malignant in childhood and 
sarcomatous in nature tumors in the adults.24 Concerning 
secondary malignant tumors, neuroblastoma and mela-
noma are the most prevalent in children 24 and metastases 
from lung, breast carcinoma and melanoma are the most 
prevalent in adults.25
c O n c l u S i O n
Based on the findings of the present study and the review 
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of the literature, we suggest that cardiac CT and MRI can 
delineate cardiac tumors and provide information essential for 
adequate diagnosis, staging and treatment planning. Cardiac 
MRI is a superior tool for cardiac mass differentiation, owing 
to the detail it provides on soft tissue.26 In cases of infiltrative 
tumor, such as angiosarcoma, MRI can provide more details 
than CT concerning mass extension, due to better soft tissue 
differentiation. The advantage of multi-slice CT is its speed 
concerning the time spent by the patient in the gantry and is 
preferred by the patients, as in the case of the patient with the 
angiosarcoma who could not complete the exam.
One major limitation of our study is that we did not com-
pare our findings with the findings of echocardiography and 
also we did not use functional techniques with MRI scanning. 
In general, we find that CT and MRI are better methods for 
preoperative planning, while cardiac ultrasound is an excellent 
method for initial diagnosis and follow up of patients.
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